Lisdexamfetamine, commonly known as Vyvanse, is a prescription drug authorized in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and adults . The medication functions as a prodrug, meaning it’s inactive until metabolized by the body, releasing dextroamphetamine